Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
EB Russo - British journal of pharmacology, 2011 - Wiley Online Library
Tetrahydrocannabinol (THC) has been the primary focus of cannabis research since 1964,
when Raphael Mechoulam isolated and synthesized it. More recently, the synergistic …
when Raphael Mechoulam isolated and synthesized it. More recently, the synergistic …
[HTML][HTML] Cannabidiol as a potential treatment for anxiety disorders
EM Blessing, MM Steenkamp, J Manzanares… - …, 2015 - Elsevier
Cannabidiol (CBD), a Cannabis sativa constituent, is a pharmacologically broad-spectrum
drug that in recent years has drawn increasing interest as a treatment for a range of …
drug that in recent years has drawn increasing interest as a treatment for a range of …
Cannabidiol adverse effects and toxicity
MA Huestis, R Solimini, S Pichini… - Current …, 2019 - ingentaconnect.com
Background: Currently, there is a great interest in the potential medical use of cannabidiol
(CBD), a non-intoxicating cannabinoid. Productive pharmacological research on CBD …
(CBD), a non-intoxicating cannabinoid. Productive pharmacological research on CBD …
Cannabidiol: a potential new alternative for the treatment of anxiety, depression, and psychotic disorders
MS García-Gutiérrez, F Navarrete, A Gasparyan… - Biomolecules, 2020 - mdpi.com
The potential therapeutic use of some Cannabis sativa plant compounds has been attracting
great interest, especially for managing neuropsychiatric disorders due to the relative lack of …
great interest, especially for managing neuropsychiatric disorders due to the relative lack of …
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients
Abstract Generalized Social Anxiety Disorder (SAD) is one of the most common anxiety
conditions with impairment in social life. Cannabidiol (CBD), one major non …
conditions with impairment in social life. Cannabidiol (CBD), one major non …
Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age
Background: Among the many cannabinoids in the cannabis plant, cannabidiol (CBD) is a
compound that does not produce the typical subjective effects of marijuana. Objectives: The …
compound that does not produce the typical subjective effects of marijuana. Objectives: The …
Safety and side effects of cannabidiol, a Cannabis sativa constituent
M Machado Bergamaschi… - Current drug …, 2011 - ingentaconnect.com
Cannabidiol (CBD), a major nonpsychotropic constituent of Cannabis, has multiple
pharmacological actions, including anxiolytic, antipsychotic, antiemetic and anti …
pharmacological actions, including anxiolytic, antipsychotic, antiemetic and anti …
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
Cannabidiol (CBD) is a major phytocannabinoid present in the Cannabis sativa plant. It
lacks the psychotomimetic and other psychotropic effects that the main plant compound Δ 9 …
lacks the psychotomimetic and other psychotropic effects that the main plant compound Δ 9 …
[HTML][HTML] The neuropsychopharmacology of cannabis: A review of human imaging studies
The laws governing cannabis are evolving worldwide and associated with changing
patterns of use. The main psychoactive drug in cannabis is Δ 9-tetrahydrocannabinol (THC) …
patterns of use. The main psychoactive drug in cannabis is Δ 9-tetrahydrocannabinol (THC) …
[HTML][HTML] Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life
AW Zuardi, NP Rodrigues, AL Silva… - Frontiers in …, 2017 - frontiersin.org
The purpose of this study was to investigate whether the anxiolytic effect of cannabidiol
(CBD) in humans follows the same pattern of an inverted U-shaped dose-effect curve …
(CBD) in humans follows the same pattern of an inverted U-shaped dose-effect curve …